• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长效促性腺激素释放激素激动剂在卵泡早期和黄体中期给药的比较。

The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist.

作者信息

Ron-El R, Herman A, Golan A, van der Ven H, Caspi E, Diedrich K

机构信息

Department of Obstetrics and Gynecology, Assaf Harofeh Medical Center, Tel Aviv University, Zerifin, Israel.

出版信息

Fertil Steril. 1990 Aug;54(2):233-7. doi: 10.1016/s0015-0282(16)53695-4.

DOI:10.1016/s0015-0282(16)53695-4
PMID:2143145
Abstract

Long-acting GnRH-a (D-Trp6 microcapsules, 3.2 mg) was intramuscularly injected, either in early follicular phase (group A) or midluteal phase (group B). Two hundred sixteen cycles were randomly allocated. Ovarian suppression was significantly more prompt in group B. Follicle cysts were diagnosed in 19% and 16% of groups A and B, respectively; their appearance and regression were significantly more rapid in group B cycles. More ampules of human menopausal gonadotropin were needed in group B. The number of oocytes retrieved was not significantly different between the groups. However, in group A more mature oocytes and more embryos with good morphology were achieved in the patients. Cancellation rate was 2.8% in groups A and B. Pregnancy rate and outcome were similar in both groups.

摘要

长效促性腺激素释放激素激动剂(D-色氨酸6微囊,3.2毫克)在卵泡早期(A组)或黄体中期(B组)进行肌肉注射。216个周期被随机分配。B组的卵巢抑制明显更迅速。A组和B组分别有19%和16%的患者被诊断出卵泡囊肿;B组周期中囊肿的出现和消退明显更快。B组需要更多的人绝经期促性腺激素安瓿。两组间获取的卵母细胞数量无显著差异。然而,A组患者获得了更多成熟卵母细胞和形态良好的胚胎。A组和B组的取消率均为2.8%。两组的妊娠率和结局相似。

相似文献

1
The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist.长效促性腺激素释放激素激动剂在卵泡早期和黄体中期给药的比较。
Fertil Steril. 1990 Aug;54(2):233-7. doi: 10.1016/s0015-0282(16)53695-4.
2
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization.促性腺激素释放激素激动剂与人类绒毛膜促性腺激素用于体外受精中触发卵泡成熟的比较
Fertil Steril. 1992 Jun;57(6):1254-8.
3
Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.使用促性腺激素释放激素(GnRH)拮抗剂加尼瑞克或GnRH激动剂曲普瑞林的长效方案预防接受卵巢刺激的女性过早出现促黄体生成素(LH)峰,临床结局相当。
Hum Reprod. 2001 Apr;16(4):644-51. doi: 10.1093/humrep/16.4.644.
4
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.在接受重组促卵泡激素和促性腺激素释放激素(GnRH)拮抗剂联合治疗进行卵巢刺激后的体外受精患者中,给予重组人绒毛膜促性腺激素、重组促黄体生成素或GnRH激动剂诱导最终卵母细胞成熟后,未补充黄体期的特征。
J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953.
5
The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.补充生长激素对体外受精结局的影响:一项前瞻性随机安慰剂对照双盲研究。
Fertil Steril. 1992 Sep;58(3):575-80. doi: 10.1016/s0015-0282(16)55266-2.
6
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.两种卵巢刺激方案与促性腺激素释放激素(GnRH)拮抗剂联合治疗用于体外受精的随机比较,这两种方案分别是在周期第2天或第5天开始使用重组促卵泡激素并与标准长效GnRH激动剂方案进行对比。
J Clin Endocrinol Metab. 2003 Jan;88(1):166-73. doi: 10.1210/jc.2002-020788.
7
Follicular and luteal cysts after treatment with gonadotropin-releasing hormone analog for in vitro fertilization.促性腺激素释放激素类似物用于体外受精治疗后的卵泡囊肿和黄体囊肿。
Fertil Steril. 1990 Jun;53(6):1091-4. doi: 10.1016/s0015-0282(16)53592-4.
8
Midluteal gonadotropin-releasing hormone analog administration in early pregnancy.孕早期黄体中期促性腺激素释放激素类似物的应用
Fertil Steril. 1990 Mar;53(3):572-4. doi: 10.1016/s0015-0282(16)53361-5.
9
Ultrashort gonadotropin-releasing hormone agonist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone.
Fertil Steril. 1992 Dec;58(6):1164-8. doi: 10.1016/s0015-0282(16)55563-0.
10
Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.对于接受体外受精或卵胞浆内单精子注射治疗的不孕女性,在月经周期的不同阶段开始卵巢刺激时的灵活性。
Fertil Steril. 2016 Aug;106(2):334-341.e1. doi: 10.1016/j.fertnstert.2016.04.006. Epub 2016 Apr 22.

引用本文的文献

1
Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis.辅助生殖的控制性卵巢刺激方案:一项网状荟萃分析。
Cochrane Database Syst Rev. 2025 Jul 1;7(7):CD012586. doi: 10.1002/14651858.CD012586.pub2.
2
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2025 Jan 9;1(1):CD006919. doi: 10.1002/14651858.CD006919.pub5.
3
Application value of Early-Follicular Phase Long-Acting Gonadotropin-Releasing Hormone Agonist Long Protocol in patients with resistant ovary syndrome.
早卵泡期长效促性腺激素释放激素激动剂长方案在卵巢抵抗综合征患者中的应用价值。
BMC Pregnancy Childbirth. 2023 Mar 15;23(1):178. doi: 10.1186/s12884-023-05477-w.
4
No significant long-term complications from inadvertent exposure to gonadotropin-releasing hormone agonist during early pregnancy in mothers and offspring: a retrospective analysis.母亲和后代在妊娠早期意外接触促性腺激素释放激素激动剂无明显长期并发症:回顾性分析。
Reprod Biol Endocrinol. 2021 Mar 20;19(1):46. doi: 10.1186/s12958-021-00732-1.
5
Analysis of the Number of Euploid Embryos in Preimplantation Genetic Testing Cycles With Early-Follicular Phase Long-Acting Gonadotropin-Releasing Hormone Agonist Long Protocol.早卵泡期长效促性腺激素释放激素激动剂长方案行胚胎植入前遗传学检测周期中整倍体胚胎数分析。
Front Endocrinol (Lausanne). 2020 Jul 21;11:424. doi: 10.3389/fendo.2020.00424. eCollection 2020.
6
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2015 Nov 9;2015(11):CD006919. doi: 10.1002/14651858.CD006919.pub4.
7
Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles.长效促性腺激素释放激素激动剂(GnRHa)单次给药与短效GnRHa每日给药在体外受精-胚胎移植周期中的临床疗效比较。
J Korean Med Sci. 2008 Aug;23(4):662-6. doi: 10.3346/jkms.2008.23.4.662.
8
Different ovarian stimulation protocols for women with diminished ovarian reserve.针对卵巢储备功能减退女性的不同卵巢刺激方案。
J Assist Reprod Genet. 2007 Dec;24(12):597-611. doi: 10.1007/s10815-007-9181-2. Epub 2007 Nov 22.
9
Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response.戈舍瑞林(长效剂型)单次给药与醋酸亮丙瑞林每日多次给药在体外受精治疗中垂体抑制作用的比较:卵巢反应的临床内分泌学研究
J Assist Reprod Genet. 2002 Jul;19(7):313-8. doi: 10.1023/a:1016054424966.
10
Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.在使用促性腺激素释放激素类似物抑制垂体期间,口服避孕药预处理可有效降低功能性卵巢囊肿形成的发生率。
J Assist Reprod Genet. 1998 Nov;15(10):599-604. doi: 10.1023/a:1020381310860.